Cholesterol DrugsVideo
Babies in the Womb May Already Be Learning Language
Some Doctors Prescribe Antibiotics Because Parents Want Them
What Kids Wear Could Determine How Much Exercise They Get
Few College Students Have Received the H1N1 Vaccine
Night Lights Could Lead to Depression
Cervarix Has Been Approved by the FDA
The FDA Is Studying the Effects of Lasik Surgery
Painkillers Can Dull the Effects of Childhood Vaccines
Childbirth May Becoming More Complicated
Botox Sponges Might Help Nose Allergies
The FDA Advises on How to Properly Dispose of Medicine
A French Study Shows Cell Phones Do Not Affect Humans
MRIs May Lead to More Back Surgery
Your More Likely to Wash Your Hands If Someone's WatchingCategories
- Allergy
- Alzheimer's Disease
- Arthritis
- Asthma
- Breast Cancer
- Cardio Health
- Cholesterol
- Cold and Flu
- Colon Cancer
- Diabetes
- Dieting
- Epilepsy
- Hair Loss
- Headache
- Heartburn
- HIV & AIDS
- Kidney Health
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Sclerosis
- Men's Health
- Mental Health
- Nutrition
- Osteoporosis
- Parkinson's Disease
- Prostate Health
- Skin Health
- Sleep Disorders
- Women's Health
- General
Multaq Sanctioned for Heart Rhythm Disorders
Posted on 07/02/2009, 10:58
By -- Scott Roberts
Atrial fibrillation or atrial flutter
THURSDAY, July 2 (HealthDay News) -- Multaq (dronedarone) tablets have been approved by the U.S. Food and Drug Administration to promote a normal heart rhythm in people with atrial fibrillation or atrial flutter. These conditions cause the heart to beat too quickly and can prevent it from pumping blood correctly.
The drug's label, however, will contain a "black box" warning that the medication could cause deadly reactions in people with recent severe heart failure, the agency said Thursday in a news release.
In clinical testing involving more than 4,000 people, Multaq lowered the rates of cardiac hospitalization or death from any cause by 24 percent, compared to an inactive placebo, the FDA said. The most common side effects were diarrhea, nausea, vomiting, fatigue and weakness.
Multaq is produced by French drug maker Sanofi-Aventis.
More information
The FDA has more about this approval.
Copyright © 2009 ScoutNews, LLC. All rights reserved.
BigHealthTree.com Disclaimer
Bighealthtree.com Does Not Provide Medical Advice. This site, including the above information, is for informational purposes only and is not a substitute for professional medical or health advice. Always seek the advice of your physician or a qualified health or medical professional before starting any new treatment, changing existing treatment, or altering your current exercise and/or diet program. If you think you are having a medical emergency, call 911 (or the emergency services in your area) or your doctor immediately.
Rating: 3.1 / 5 (7 votes)
 |
 |
Comments (0):
Be the first to comment on this article.
Post a comment